Latest News

• share
• favorite_border

University Health Network (UHN), Canada’s #1 hospital and a leading healthcare institution dedicated to providing exceptional patient care & advancing biomedical research, and YouTube Health, a global initiative committed to making high-quality health information available, are thrilled to announce a strategic partnership aimed at delivering timely, reliable & accurate health information to Canadians.

• share
• favorite_border

Large-language models could soon become essential tools for diagnosing diseases. To protect people’s privacy, medical professionals must drive the development and deployment of such models.

• share
• favorite_border

In 2014, Dr. Andrea Furlan, a physician at Toronto Rehab and a leader in chronic pain treatment, had a vision: to bring together a group of experts who could equip health care professionals in the community with the knowledge they'd need to provide proper pain treatment.

• share
• favorite_border

When Teresa Tiano had her stomach removed, she didn't know how she was going to survive.

• share
• favorite_border

​Researchers at UHN's Krembil Brain Institute have uncovered links between structural changes in the brain and neuropsychiatric symptoms of various neurodegenerative diseases.

• share
• favorite_border

A new international study published in and presented as a late-breaking abstract at the American Association of Neurological Surgeons (AANS) annual conference, shows great promise for patients with glioblastoma. Drs. Farshad Nassiri and Gelareh Zadeh, neurosurgeons and scientists at the University Health Network (UHN) in Toronto, published the results of a Phase 1/2 clinical trial investigating the safety and effectiveness of a novel therapy which combines the injection of an oncolytic virus – a virus that targets and kills cancer cells – directly into the tumour, with intravenous immunotherapy.

• share
• favorite_border

In a study published in Nature Communications, a team led by Krembil Brain Institute at UHN Senior Scientists, Drs. Lorraine Kalia and Suneil Kalia, and University of Toronto (U of T) Professor, Dr. Philip M. Kim, identified a protein-protein interaction that contributes to Parkinson's disease. In the disease, a protein called α-synuclein (a-syn) accumulates in the brain and leads to cell death.

• share
• favorite_border

Global pharmaceutical company Takeda has agreed to exclusively license a group of small molecules that target tau – a protein in which misfolding and aggregation are believed to be a cause of Alzheimer’s disease.

• share
• favorite_border

A single-dose of the antiviral drug peginterferon lambda reduced by half the risk of hospitalization or a visit to the Emergency Department due to COVID-19, according to a study published today in the New England Journal of Medicine.

• share
• favorite_border

(Toronto, Oct. 3, 2022) – University Health Network (UHN) is pleased to announce that Dr. Jaideep Bains will be joining our team as the new Director of the Krembil Research Institute. The Krembil Research Institute, one of the principal institutes within UHN, comprises the Krembil Brain Institute, the Schroeder Arthritis Institute and the Donald K.

• share
• favorite_border

UHN’s Ajmera Transplant Centre and The Centre for Living Organ Donation announce today the launch of a new campaign, Great Actions Leave a Mark, www.greatactions.ca. The campaign showcases through artistic photos and video, the stories and scars (the mark) from 39 living organ donors and transplant recipients across Canada.

• share
• favorite_border

Anonymous $11M donation will go toward research, care for Neurofibromatosis patients

• share
• favorite_border

A study published in the Journal of the American Medical Association Surgery is the first in North America to demonstrate that living-donor liver transplant is a viable option for patients who have systemically controlled colorectal cancer and liver tumors that cannot be surgically removed.

• share
• favorite_border

Boys are 10 times more likely to be vaccinated against human papillomavirus (HPV) in provinces where the vaccine is publicly funded than in places where it is not, according to a new study published by a researcher at the Princess Margaret Cancer Centre and colleagues at McGill University, Université de Montréal, and the Jewish General Hospital.

• share
• favorite_border

The Canadian Distributed Infrastructure for Genomics (CanDIG) is a collaboration of computer scientists, AI specialists, clinicians, and geneticists working together to enable studies needed to address the health challenges faced by Canadians.

• share
• favorite_border

According to the latest Association of University Technology Managers (AUTM) North American Annual Licensing Survey, the University Health Network (UHN) ranks as the #1 research commercialization institution in Canada for the second year running according to gross licensing revenue from the research it has commercialized.

• share
• favorite_border

A new study from the Peter Munk Cardiac Centre reveals that patients who survive an aortic dissection often fail to receive comprehensive post-surgical follow-up care leaving them vulnerable to a lifetime of sustained risk.

• share
• favorite_border

Ankylosing spondylitis is a painful and inflammatory form of axial spondyloarthritis (SpA) which affects 1-2% of Canadians and causes inflammation in the spine, joints, eyes, gut and skin. In a new paper recently published in the journal Science Translational Medicine, researchers at the Schroeder Arthritis Institute at UHN have made a discovery that could lead to new treatments for SpA.

• share
• favorite_border

Physicians recommend that patients with pulmonary hypertension avoid pregnancy, given the high risk of death for the mother and baby. However, Candice Cruise was unaware of her condition until she reached 21 weeks of pregnancy.

• share
• favorite_border

Princess Margaret Cancer Centre researchers have made new findings which greatly improve detection of the human papillomavirus (HPV) in the bloodstream and could further hone precision treatment of the illness.